nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—HTR1A—bipolar disorder	0.325	0.37	CbGaD
Vilazodone—SLC6A4—bipolar disorder	0.278	0.316	CbGaD
Vilazodone—DRD2—bipolar disorder	0.276	0.314	CbGaD
Vilazodone—HTR1A—telencephalic ventricle—bipolar disorder	0.00493	0.174	CbGeAlD
Vilazodone—DRD2—telencephalic ventricle—bipolar disorder	0.00446	0.157	CbGeAlD
Vilazodone—SLC6A4—blood plasma—bipolar disorder	0.00265	0.0936	CbGeAlD
Vilazodone—CYP3A4—urine—bipolar disorder	0.00249	0.0878	CbGeAlD
Vilazodone—CYP2D6—urine—bipolar disorder	0.00245	0.0864	CbGeAlD
Vilazodone—HTR1A—blood plasma—bipolar disorder	0.00235	0.0831	CbGeAlD
Vilazodone—Aripiprazole—DRD5—bipolar disorder	0.00149	0.191	CrCbGaD
Vilazodone—CYP3A4—blood plasma—bipolar disorder	0.0013	0.0458	CbGeAlD
Vilazodone—CYP2D6—blood plasma—bipolar disorder	0.00128	0.0451	CbGeAlD
Vilazodone—SLC6A4—nervous system—bipolar disorder	0.000788	0.0278	CbGeAlD
Vilazodone—Aripiprazole—DRD4—bipolar disorder	0.000762	0.0978	CrCbGaD
Vilazodone—HTR1A—nervous system—bipolar disorder	0.000699	0.0247	CbGeAlD
Vilazodone—HTR1A—cerebellum—bipolar disorder	0.000658	0.0233	CbGeAlD
Vilazodone—Aripiprazole—DRD3—bipolar disorder	0.000657	0.0843	CrCbGaD
Vilazodone—Aripiprazole—DRD1—bipolar disorder	0.000645	0.0828	CrCbGaD
Vilazodone—DRD2—nervous system—bipolar disorder	0.000632	0.0223	CbGeAlD
Vilazodone—SLC6A4—brain—bipolar disorder	0.000602	0.0213	CbGeAlD
Vilazodone—DRD2—cerebellum—bipolar disorder	0.000595	0.021	CbGeAlD
Vilazodone—Aripiprazole—HTR2C—bipolar disorder	0.000552	0.0708	CrCbGaD
Vilazodone—Trazodone—HTR2C—bipolar disorder	0.000549	0.0705	CrCbGaD
Vilazodone—Aripiprazole—HTR1A—bipolar disorder	0.000536	0.0688	CrCbGaD
Vilazodone—HTR1A—brain—bipolar disorder	0.000535	0.0189	CbGeAlD
Vilazodone—Trazodone—HTR1A—bipolar disorder	0.000533	0.0684	CrCbGaD
Vilazodone—DRD2—brain—bipolar disorder	0.000483	0.0171	CbGeAlD
Vilazodone—Aripiprazole—SLC6A4—bipolar disorder	0.000457	0.0587	CrCbGaD
Vilazodone—Trazodone—SLC6A4—bipolar disorder	0.000455	0.0584	CrCbGaD
Vilazodone—Aripiprazole—DRD2—bipolar disorder	0.000455	0.0584	CrCbGaD
Vilazodone—CYP3A4—nervous system—bipolar disorder	0.000386	0.0136	CbGeAlD
Vilazodone—CYP2D6—nervous system—bipolar disorder	0.00038	0.0134	CbGeAlD
Vilazodone—CYP2D6—cerebellum—bipolar disorder	0.000357	0.0126	CbGeAlD
Vilazodone—Aripiprazole—HTR2A—bipolar disorder	0.000352	0.0451	CrCbGaD
Vilazodone—Trazodone—HTR2A—bipolar disorder	0.00035	0.0449	CrCbGaD
Vilazodone—CYP2D6—brain—bipolar disorder	0.00029	0.0103	CbGeAlD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000118	0.00138	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—IMPA1—bipolar disorder	0.000117	0.00138	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—DRD4—bipolar disorder	0.000115	0.00135	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000114	0.00134	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000114	0.00134	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000113	0.00133	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000113	0.00133	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—GSK3B—bipolar disorder	0.000112	0.00132	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000111	0.0013	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.000111	0.0013	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00011	0.0013	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—NTRK1—bipolar disorder	0.00011	0.00129	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—ADM—bipolar disorder	0.000108	0.00128	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—ADCY2—bipolar disorder	0.000108	0.00128	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000107	0.00126	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000107	0.00126	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—TSHB—bipolar disorder	0.000106	0.00124	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—TACR1—bipolar disorder	0.000106	0.00124	CbGpPWpGaD
Vilazodone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000104	0.00123	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000104	0.00123	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000101	0.00119	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.000101	0.00119	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NDUFV2—bipolar disorder	9.98e-05	0.00118	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	9.92e-05	0.00117	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	9.72e-05	0.00115	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	9.72e-05	0.00115	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	9.7e-05	0.00114	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKR1C4—bipolar disorder	9.67e-05	0.00114	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—ADM—bipolar disorder	9.51e-05	0.00112	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	9.42e-05	0.00111	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—TACR1—bipolar disorder	9.26e-05	0.00109	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—TSHB—bipolar disorder	9.26e-05	0.00109	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DGKH—bipolar disorder	9.25e-05	0.00109	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	9.14e-05	0.00108	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NR1D1—bipolar disorder	8.68e-05	0.00102	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—TAC1—bipolar disorder	8.6e-05	0.00101	CbGpPWpGaD
Vilazodone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	8.48e-05	0.000999	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD5—bipolar disorder	8.46e-05	0.000997	CbGpPWpGaD
Vilazodone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	8.45e-05	0.000995	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR2C—bipolar disorder	8.43e-05	0.000994	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD1—bipolar disorder	8.43e-05	0.000994	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DGKH—bipolar disorder	8.4e-05	0.00099	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NCAN—bipolar disorder	8.31e-05	0.000978	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—RGS4—bipolar disorder	8.3e-05	0.000978	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD3—bipolar disorder	8.17e-05	0.000962	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—SLC5A3—bipolar disorder	8.14e-05	0.000959	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DGKH—bipolar disorder	8.12e-05	0.000957	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	7.93e-05	0.000934	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD4—bipolar disorder	7.93e-05	0.000934	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD5—bipolar disorder	7.68e-05	0.000905	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR1A—bipolar disorder	7.67e-05	0.000903	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—TAC1—bipolar disorder	7.55e-05	0.00089	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—RGS4—bipolar disorder	7.54e-05	0.000888	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD5—bipolar disorder	7.43e-05	0.000875	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2C—bipolar disorder	7.41e-05	0.000872	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—DRD1—bipolar disorder	7.41e-05	0.000872	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD2—bipolar disorder	7.39e-05	0.00087	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DGKH—bipolar disorder	7.38e-05	0.000869	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—RGS4—bipolar disorder	7.29e-05	0.000858	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—DRD3—bipolar disorder	7.17e-05	0.000845	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	7.03e-05	0.000828	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	6.96e-05	0.00082	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—DRD4—bipolar disorder	6.96e-05	0.00082	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—COMT—bipolar disorder	6.94e-05	0.000818	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—MAOA—bipolar disorder	6.89e-05	0.000812	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—GSK3B—bipolar disorder	6.84e-05	0.000806	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	6.84e-05	0.000806	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—POMC—bipolar disorder	6.82e-05	0.000804	CbGpPWpGaD
Vilazodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	6.81e-05	0.000802	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	6.79e-05	0.0008	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD5—bipolar disorder	6.75e-05	0.000795	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—RGS4—bipolar disorder	6.62e-05	0.00078	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—TRPC3—bipolar disorder	6.41e-05	0.000756	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADM—bipolar disorder	6.12e-05	0.000721	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—POMC—bipolar disorder	5.99e-05	0.000706	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	5.97e-05	0.000703	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—TSHB—bipolar disorder	5.96e-05	0.000702	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PDE4B—bipolar disorder	5.96e-05	0.000702	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—TACR1—bipolar disorder	5.96e-05	0.000702	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—IMPA2—bipolar disorder	5.94e-05	0.0007	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CLOCK—bipolar disorder	5.88e-05	0.000693	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—TRPC3—bipolar disorder	5.82e-05	0.000686	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—TPH2—bipolar disorder	5.73e-05	0.000675	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CACNB2—bipolar disorder	5.73e-05	0.000675	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—TSHB—bipolar disorder	5.73e-05	0.000675	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—DPYD—bipolar disorder	5.64e-05	0.000664	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—TRPC3—bipolar disorder	5.63e-05	0.000663	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADM—bipolar disorder	5.56e-05	0.000655	CbGpPWpGaD
Vilazodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	5.52e-05	0.000651	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	5.43e-05	0.000639	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—TSHB—bipolar disorder	5.41e-05	0.000638	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PDE4B—bipolar disorder	5.41e-05	0.000638	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—TACR1—bipolar disorder	5.41e-05	0.000638	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKR1C4—bipolar disorder	5.39e-05	0.000635	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADM—bipolar disorder	5.37e-05	0.000633	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CACNA1C—bipolar disorder	5.24e-05	0.000618	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PDE4B—bipolar disorder	5.23e-05	0.000617	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—TSHB—bipolar disorder	5.23e-05	0.000617	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—TACR1—bipolar disorder	5.23e-05	0.000617	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR2A—bipolar disorder	5.17e-05	0.00061	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TRPC3—bipolar disorder	5.11e-05	0.000602	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3C2A—bipolar disorder	5.11e-05	0.000602	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DGKH—bipolar disorder	4.96e-05	0.000585	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADM—bipolar disorder	4.88e-05	0.000575	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—TAC1—bipolar disorder	4.86e-05	0.000573	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2C—bipolar disorder	4.77e-05	0.000562	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD1—bipolar disorder	4.77e-05	0.000562	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.76e-05	0.000561	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TSHB—bipolar disorder	4.75e-05	0.00056	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PDE4B—bipolar disorder	4.75e-05	0.00056	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TACR1—bipolar disorder	4.75e-05	0.00056	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKR1C4—bipolar disorder	4.74e-05	0.000558	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD3—bipolar disorder	4.62e-05	0.000544	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—SNAP25—bipolar disorder	4.58e-05	0.00054	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2A—bipolar disorder	4.54e-05	0.000535	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD5—bipolar disorder	4.54e-05	0.000535	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—COMT—bipolar disorder	4.54e-05	0.000535	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—MAOA—bipolar disorder	4.51e-05	0.000531	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—POMC—bipolar disorder	4.49e-05	0.000529	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD4—bipolar disorder	4.48e-05	0.000528	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	4.48e-05	0.000527	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RGS4—bipolar disorder	4.45e-05	0.000524	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—TAC1—bipolar disorder	4.41e-05	0.00052	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DGKH—bipolar disorder	4.36e-05	0.000513	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR1A—bipolar disorder	4.33e-05	0.00051	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD1—bipolar disorder	4.33e-05	0.00051	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2C—bipolar disorder	4.33e-05	0.00051	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—TAC1—bipolar disorder	4.27e-05	0.000503	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADCY2—bipolar disorder	4.22e-05	0.000497	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD3—bipolar disorder	4.19e-05	0.000494	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2C—bipolar disorder	4.18e-05	0.000493	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD1—bipolar disorder	4.18e-05	0.000493	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD2—bipolar disorder	4.17e-05	0.000492	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—POMC—bipolar disorder	4.13e-05	0.000487	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD4—bipolar disorder	4.07e-05	0.000479	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ADCY2—bipolar disorder	4.06e-05	0.000478	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD3—bipolar disorder	4.05e-05	0.000477	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—IMPA1—bipolar disorder	4.01e-05	0.000473	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD5—bipolar disorder	3.99e-05	0.00047	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR1A—bipolar disorder	3.93e-05	0.000464	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD4—bipolar disorder	3.93e-05	0.000464	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RGS4—bipolar disorder	3.91e-05	0.00046	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—IMPA2—bipolar disorder	3.88e-05	0.000457	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TAC1—bipolar disorder	3.88e-05	0.000457	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADCY2—bipolar disorder	3.83e-05	0.000451	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2C—bipolar disorder	3.8e-05	0.000448	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD1—bipolar disorder	3.8e-05	0.000448	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD2—bipolar disorder	3.79e-05	0.000447	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADCY2—bipolar disorder	3.7e-05	0.000436	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD3—bipolar disorder	3.68e-05	0.000434	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—POMC—bipolar disorder	3.63e-05	0.000427	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD4—bipolar disorder	3.57e-05	0.000421	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—COMT—bipolar disorder	3.47e-05	0.000409	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MAOA—bipolar disorder	3.45e-05	0.000406	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TRPC3—bipolar disorder	3.44e-05	0.000405	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NDUFV2—bipolar disorder	3.41e-05	0.000402	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADCY2—bipolar disorder	3.36e-05	0.000396	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKR1C4—bipolar disorder	3.3e-05	0.000389	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADM—bipolar disorder	3.28e-05	0.000387	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	3.2e-05	0.000377	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TSHB—bipolar disorder	3.2e-05	0.000377	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TACR1—bipolar disorder	3.2e-05	0.000377	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TRPC3—bipolar disorder	3.02e-05	0.000356	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NR1D1—bipolar disorder	2.97e-05	0.00035	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.93e-05	0.000346	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	2.92e-05	0.000344	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADM—bipolar disorder	2.88e-05	0.000339	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NCAN—bipolar disorder	2.84e-05	0.000334	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TSHB—bipolar disorder	2.81e-05	0.000331	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDE4B—bipolar disorder	2.81e-05	0.000331	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TACR1—bipolar disorder	2.81e-05	0.000331	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—bipolar disorder	2.81e-05	0.000331	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.78e-05	0.000328	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	2.66e-05	0.000313	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.62e-05	0.000309	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TAC1—bipolar disorder	2.61e-05	0.000307	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	2.57e-05	0.000302	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD1—bipolar disorder	2.56e-05	0.000301	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	2.56e-05	0.000301	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	2.49e-05	0.000293	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD3—bipolar disorder	2.48e-05	0.000292	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	2.47e-05	0.00029	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD4—bipolar disorder	2.4e-05	0.000283	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	2.34e-05	0.000275	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	2.33e-05	0.000275	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1A—bipolar disorder	2.32e-05	0.000274	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TAC1—bipolar disorder	2.29e-05	0.00027	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	2.26e-05	0.000267	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	2.25e-05	0.000266	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—POMC—bipolar disorder	2.25e-05	0.000265	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2C—bipolar disorder	2.24e-05	0.000264	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD1—bipolar disorder	2.24e-05	0.000264	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD2—bipolar disorder	2.24e-05	0.000264	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—INS—bipolar disorder	2.23e-05	0.000263	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.23e-05	0.000263	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK2—bipolar disorder	2.18e-05	0.000257	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD3—bipolar disorder	2.17e-05	0.000256	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GSK3A—bipolar disorder	2.16e-05	0.000255	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.16e-05	0.000254	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—POMC—bipolar disorder	2.12e-05	0.00025	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD4—bipolar disorder	2.11e-05	0.000249	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—POMC—bipolar disorder	2.05e-05	0.000242	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	2.03e-05	0.000239	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.01e-05	0.000237	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADCY2—bipolar disorder	1.99e-05	0.000234	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	1.98e-05	0.000233	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—S100B—bipolar disorder	1.97e-05	0.000232	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TSHB—bipolar disorder	1.96e-05	0.000231	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TPH2—bipolar disorder	1.96e-05	0.000231	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.96e-05	0.000231	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.94e-05	0.000229	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DPYD—bipolar disorder	1.93e-05	0.000227	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—POMC—bipolar disorder	1.86e-05	0.000219	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NCAN—bipolar disorder	1.86e-05	0.000219	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.82e-05	0.000214	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.79e-05	0.000211	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK1—bipolar disorder	1.78e-05	0.00021	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.75e-05	0.000206	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NRG1—bipolar disorder	1.74e-05	0.000205	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—S100B—bipolar disorder	1.73e-05	0.000204	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	1.57e-05	0.000185	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.57e-05	0.000185	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NRG1—bipolar disorder	1.53e-05	0.00018	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.39e-05	0.000163	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—bipolar disorder	1.38e-05	0.000162	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.31e-05	0.000155	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TSHB—bipolar disorder	1.28e-05	0.000151	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TPH2—bipolar disorder	1.28e-05	0.000151	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.28e-05	0.000151	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	1.26e-05	0.000149	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DPYD—bipolar disorder	1.26e-05	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—POMC—bipolar disorder	1.25e-05	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INS—bipolar disorder	1.25e-05	0.000147	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—COMT—bipolar disorder	1.19e-05	0.00014	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MAOA—bipolar disorder	1.18e-05	0.000139	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.17e-05	0.000138	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.14e-05	0.000134	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GSK3B—bipolar disorder	1.11e-05	0.000131	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—POMC—bipolar disorder	1.1e-05	0.00013	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INS—bipolar disorder	1.09e-05	0.000129	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.02e-05	0.000121	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—bipolar disorder	9.59e-06	0.000113	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ADCY2—bipolar disorder	9.06e-06	0.000107	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—COMT—bipolar disorder	7.76e-06	9.14e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MAOA—bipolar disorder	7.7e-06	9.08e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—POMC—bipolar disorder	7.67e-06	9.04e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—INS—bipolar disorder	7.63e-06	8.99e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—bipolar disorder	6.27e-06	7.39e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—POMC—bipolar disorder	5.02e-06	5.91e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INS—bipolar disorder	4.99e-06	5.88e-05	CbGpPWpGaD
